Erectile Dysfunction in Patients Treated with Selpercatinib for RET-Altered Thyroid Cancer

Thyroid. 2024 Sep;34(9):1177-1180. doi: 10.1089/thy.2024.0129. Epub 2024 Jul 19.

Antonio Matrone¹, Matthias Kroiss^{2

3}, Matti L Gild^{4

5}, Sarah Hamidi⁶, Cyrus Michael Sayehli⁷, Rhonda Siddal⁴, Carla Gambale¹, Alessandro Prete¹, Mimi I Hu⁶, Bruce G Robinson^{4

5}, Rossella Elisei¹

¹ Department of Clinical and Experimental Medicine, Unit of Endocrinology, Pisa University Hospital, Pisa, Italy.
² Department of Internal Medicine IV, Chair of Endocrinology/Diabetology, LMU University Hospital, LMU Munich, Munchen, Germany.
³ Department of Internal Medicine I, Chair of Endocrinology/Diabetology, University Hospital Würzburg, University of Würzburg, Munchen, Germany.
⁴ Department of Endocrinology and Diabetes, Royal North Shore Hospital, Sydney, Australia.
⁵ Faculty of Medicine and Health, University of Sydney, Sydney, Australia.
⁶ Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer, Houston, Texas, USA.
⁷ Interdisciplinary Trial Center with Early Clinical Trial Unit, University Hospital Würzburg, Wurzburg, Germany.

No abstract available

Publication types